Retraction
mir-204-5p Acts as a Tumor Suppressor by Targeting DNM2 in Osteosarcoma Cells
Paper Information
Record ID:
42286
Author(s):
Journal:
Publication Date:
February 09, 2022
Retraction Date:
January 21, 2023
(2.8 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (5)
5
Total Citations3
Post-Retraction(60.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
1
After 2+ years
759
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing mir-204-5p Acts as a Tumor Suppressor by Targeting...
Unknown Authors
Unknown Journal
Published: Feb 2025
759 days after retraction
Unraveling the role of Xist RNA in cardiovascular pathogenesis
Waleed Hassan Almalki
Pathology - Research and Practice
Published: Nov 2023
2 citations
2 citations
294 days after retraction
MiR-204-5p-targeted AP1S2 is necessary for papillary thyroid carcinoma
Yulu Gu, Xin Zhang, Yong Li et al. (10 authors)
Molecular and Cellular Endocrinology
Published: Jun 2023
4 citations
4 citations
145 days after retraction
Retracted: mir‐204‐5p Acts as a Tumor Suppressor by Targeting DNM2 in Osteosarcoma Cells
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
20 days before retraction
Quick Stats
Total Citations:
5
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025